Lv11
66 积分 2024-05-29 加入
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
7小时前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
9天前
已完结
Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer
9天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
12天前
已完结
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer
15天前
已完结
The Brazilian Society of Surgical Oncology (SBCO) Guidelines for the Treatment of Exocrine Pancreatic Insufficiency in Cancer Patients
21天前
已完结
EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma
21天前
已关闭
EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma
21天前
已关闭
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
21天前
已完结
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
26天前
已完结
皖公网安备34019202002308
